Publication Bias The assessment of publication bias across the five analyzed outcomes - semaglutide, exenatide, liraglutide, orlistat, and post-discontinuation at 12 weeks - utilized multiple statistical methods, including Beggs rank correlation test, Eggers test of the intercept, Fail-safe N, and Duval and Tweedies Trim and Fill method, as provided in the Appendix (Supplementary Figures 8-12)
This finding may relate to the different abilities of these agonists to target brain regions that are crucial for memory processes (Vallof et al., 2015) and group-housed (Thomsen et al., 2017) male rodents
Ongoing care is handled through monthly refill questionnaires reviewed remotely by a provider
Kidney Disease and Acute Kidney Injury Reports have also linked GLP-1 receptor agonist drugs to kidney disease and acute kidney injury, sometimes requiring dialysis or long-term treatment
Use Your HSA or FSA Account If you have a Health Savings Account or Flexible Spending Account through your employer, GLP-1 medications may be eligible expenses